Osteogenic Effects of Ion Released from Biodegradable Metallic Magnesium and Calcium Coating
Source abstract
Abstract
Abstract This study investigates the effects of ion release and pH elevation from a biodegradable metallic magnesium (Mg) –30 calcium (Ca) coating on osteogenesis using osteoblast‐like cells. The coating, formed on titanium (Ti) via magnetron sputtering, has previously been shown to enhance osteogenesis by promoting calcite formation on the Ti surface upon degradation in vitro study. However, the individual and combined roles of released Mg 2+ , Ca 2+ , and pH elevation remain unclear. To clarify these effects, culture media supplemented with Mg 2+ and Ca 2+ salts are prepared. Mg 2+ at 4–5 m m promotes early alkaline phosphatase (ALP) activity compared to the 0.9 m m control, without affecting proliferation but suppressing mineralization. Ca 2+ at 2.3–3 m m enhances ALP activity without affecting proliferation or mineralization compared to the 1.3–2.2 m m control. When both ions coexist, proliferation, ALP activity, and mineralization are enhanced compared to Mg 2+ alone, suggesting a synergistic effect. Furthermore, the elevated pH resulting from the Mg–30Ca extract more effectively promotes proliferation, accelerates the peak of ALP activity, and supports mineralization than ions co‐supplementation. These findings indicate that Mg–30Ca coatings enhance osteogenesis through both ion release and pH elevation, providing new insight into the osteogenic potential of biodegradable metallic coatings.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Magnesium Alloys: Properties and Applications · Calcium Carbonate Crystallization and Inhibition
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Regenerative and Reconstructive Dental Medicine Graduate School of Medical and Dental Sciences Institute of Science Tokyo 1‐5‐45 Yushima Bunkyo‐ku Tokyo 113‐8549 Japan
Department of Inorganic Biomaterials Laboratory for Biomaterials and Bioengineering Institute of Integrated Research Institute of Science Tokyo 2‐3‐10, Kanda‐Surugadai Chiyoda‐ku Tokyo 101‐0062 Japan
Funding
Ministry of Education, Culture, Sports, Science and Technology · Japan Society for the Promotion of Science
References (46)
Show source-provided references
1. 10.3390/jfb804004410.3390/jfb8040044 ↗
2. 10.1016/j.pnsc.2014.08.01410.1016/j.pnsc.2014.08.014 ↗
3. 10.1016/j.jma.2021.06.02410.1016/j.jma.2021.06.024 ↗
4. 10.1016/j.actbio.2014.02.00210.1016/j.actbio.2014.02.002 ↗
5. 10.1002/advs.20200080010.1002/advs.202000800 ↗
6. 10.3390/biom1104050610.3390/biom11040506 ↗
7. 10.1016/j.drudis.2018.01.04910.1016/j.drudis.2018.01.049 ↗
8. 10.1016/j.actbio.2014.08.01110.1016/j.actbio.2014.08.011 ↗
9. 10.1016/j.biomaterials.2007.12.02110.1016/j.biomaterials.2007.12.021 ↗
10. 10.1007/s13577-012-0041-810.1007/s13577-012-0041-8 ↗
11. 10.1016/S0921-5093(97)00806-X10.1016/S0921-5093(97)00806-X ↗
12. 10.1080/10667857.2016.121278010.1080/10667857.2016.1212780 ↗
13. 10.3109/1745367860899439310.3109/17453678608994393 ↗
14. 10.1016/j.dental.2006.06.02510.1016/j.dental.2006.06.025 ↗
15. 10.1111/prd.1217910.1111/prd.12179 ↗
16. 10.2147/IJN.S25548610.2147/IJN.S255486 ↗
17. 10.1021/acsabm.4c0134110.1021/acsabm.4c01341 ↗
18. 10.1021/acs.langmuir.5c0174610.1021/acs.langmuir.5c01746 ↗
19. 10.1021/acsabm.3c0086010.1021/acsabm.3c00860 ↗
20. 10.1038/nmeth.208910.1038/nmeth.2089 ↗
21. 10.1248/yakushi.126.65110.1248/yakushi.126.651 ↗
22. 10.1016/j.actbio.2015.04.01110.1016/j.actbio.2015.04.011 ↗
23. W. H.De Jong J. W.Carraway R. E.Geertsma Biocompat. Perform. Med. Devices 2nd Ed. Woodhead Publishing2020 pp.123–166.10.1016/B978-0-08-102643-4.00007-0 ↗
24. 10.1002/jbmr.565007061310.1002/jbmr.5650070613 ↗
25. Nie X. · Regener. Biomater. · 2020 · 7 · 53
26. 10.1007/s12011-017-0948-810.1007/s12011-017-0948-8 ↗
27. 10.1016/j.actbio.2019.06.00110.1016/j.actbio.2019.06.001 ↗
28. 10.1684/mrh.2017.042210.1684/mrh.2017.0422 ↗
29. 10.1590/1414-431x2016525710.1590/1414-431x20165257 ↗
30. 10.1021/cg401619s10.1021/cg401619s ↗
31. 10.1016/j.bbrc.2014.07.00410.1016/j.bbrc.2014.07.004 ↗
32. 10.1684/mrh.2011.027110.1684/mrh.2011.0271 ↗
33. 10.1074/jbc.M01092120010.1074/jbc.M010921200 ↗
34. Duncan R. L. · Semin. Nephrol. · 1998 · 18 · 178
35. 10.1016/j.biomaterials.2005.01.00610.1016/j.biomaterials.2005.01.006 ↗
36. 10.1039/D2BM00742H10.1039/D2BM00742H ↗
37. 10.1021/la00061a01910.1021/la00061a019 ↗
38. 10.1016/j.bbrep.2017.02.00110.1016/j.bbrep.2017.02.001 ↗
39. 10.3389/fcell.2016.0004010.3389/fcell.2016.00040 ↗
40. 10.1002/(SICI)1097-4644(19980101)68:1<83::AID-JCB8>3.0.CO;2-S10.1002/(SICI)1097-4644(19980101)68:1<83::AID-JCB8>3.0.CO;2-S ↗
41. 10.1007/BF0100253710.1007/BF01002537 ↗
42. 10.1210/jc.83.11.395110.1210/jc.83.11.3951 ↗
43. 10.1093/clinchem/11.5.57010.1093/clinchem/11.5.570 ↗
44. 10.1074/jbc.M70111620010.1074/jbc.M701116200 ↗
45. Jr B. G. R. · Mol. Cancer Res. · 2001 · 12 · 61
46. 10.1016/j.bioactmat.2024.12.02010.1016/j.bioactmat.2024.12.020 ↗